Identification and characterization of a novel FBN1 gene variant in an extended family with variable clinical phenotype of Marfan syndrome

被引:4
作者
Ergoren, Mahmut Cerkez [1 ]
Turkgenc, Burcu [2 ]
Terali, Kerem [3 ]
Rodoplu, Orhan [4 ]
Verstraeten, Aline [5 ]
Van Laer, Lut [5 ]
Mocan, Gamze [6 ]
Loeys, Bart [5 ]
Tetik, Omer [7 ]
Temel, Sehime G. [8 ,9 ,10 ]
机构
[1] Near East Univ, Dept Med Biol, Fac Med, Nicosia, Cyprus
[2] Acibadem Genet Diagnost Ctr, Istanbul, Turkey
[3] Near East Univ, Dept Med Biochem, Fac Med, Nicosia, Cyprus
[4] Private Yalova Hosp, Dept Cardiovasc Surg, Yalova, Turkey
[5] Univ Antwerp, Ctr Med Genet, Antwerp Univ Hosp, Antwerp, Belgium
[6] Near East Univ, Dept Pathol, Fac Med, Nicosia, Cyprus
[7] Celal Bayar Univ, Dept Cardiovasc Surg, Manisa, Turkey
[8] Uludag Univ, Dept Histol & Embryol, Bursa, Turkey
[9] Uludag Univ, Dept Med Genet, Bursa, Turkey
[10] Near East Univ, Dept Histol & Embryol, Fac Med, Nicosia, Cyprus
关键词
FACTOR-LIKE DOMAINS; FIBRILLIN-1; FBN1; MUTATIONS; GENOTYPE; SEQUENCE; PROTEIN; EXPRESSION;
D O I
10.1080/03008207.2018.1472589
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Marfan syndrome (MFS) is a multi-systemic autosomal dominant condition caused by mutations in the gene (FBN1) coding for fibrillin-1. Mutations have been associated with a wide range of overlapping phenotypes. Here, we report on an extended family presenting with skeletal, ocular and cardiovascular clinical features. The 37-year-old male propositus, who had chest pain, dyspnea and shortness of breath, was first diagnosed based on the revised Ghent criteria and then subjected to molecular genetic analyses. FBN1 sequencing of the proband as well as available affected family members revealed the presence of a novel variant, c.7828G>C (p.Glu2610Gln), which was not present in any of the unaffected family members. In silico analyses demonstrated that the Glu2610 residue is part of the conserved DINE motif found at the beginning of each cbEGF domain of FBN1. The substitution of Glu2610 with Gln decreased fibrillin-1 production accordingly. Despite the fact that this variation appears to be primarily responsible for the etiology of MFS in the present family, our findings suggest that variable clinical expressions of the disease phenotype should be considered critically by the physicians.
引用
收藏
页码:146 / 154
页数:9
相关论文
共 38 条
[1]   FIBRILLIN ABNORMALITIES AND PROGNOSIS IN MARFAN-SYNDROME AND RELATED DISORDERS [J].
AOYAMA, T ;
FRANCKE, U ;
GASNER, C ;
FURTHMAYR, H .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 58 (02) :169-176
[2]   The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele [J].
Aubart, Melodie ;
Gross, Marie-Sylvie ;
Hanna, Nadine ;
Zabot, Marie-Therese ;
Sznajder, Marc ;
Detaint, Delphine ;
Gouya, Laurent ;
Jondeau, Guillaume ;
Boileau, Catherine ;
Stheneur, Chantal .
HUMAN MOLECULAR GENETICS, 2015, 24 (10) :2764-2770
[3]   Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events [J].
Baudhuin, Linnea M. ;
Kotzer, Katrina E. ;
Lagerstedt, Susan A. .
GENETICS IN MEDICINE, 2015, 17 (03) :177-187
[4]   Molecular genetics of Marfan syndrome [J].
Boileau, C ;
Jondeau, G ;
Mizuguchi, T ;
Matsumoto, N .
CURRENT OPINION IN CARDIOLOGY, 2005, 20 (03) :194-200
[5]   MUTATIONS IN THE HUMAN GENE FOR FIBRILLIN-1 (FBN1) IN THE MARFAN-SYNDROME AND RELATED DISORDERS [J].
DIETZ, HC ;
PYERITZ, RE .
HUMAN MOLECULAR GENETICS, 1995, 4 :1799-1809
[6]   MARFAN-SYNDROME CAUSED BY A RECURRENT DENOVO MISSENSE MUTATION IN THE FIBRILLIN GENE [J].
DIETZ, HC ;
CUTTING, GR ;
PYERITZ, RE ;
MASLEN, CL ;
SAKAI, LY ;
CORSON, GM ;
PUFFENBERGER, EG ;
HAMOSH, A ;
NANTHAKUMAR, EJ ;
CURRISTIN, SM ;
STETTEN, G ;
MEYERS, DA ;
FRANCOMANO, CA .
NATURE, 1991, 352 (6333) :337-339
[7]   Solution structure of a pair of calcium-binding epidermal growth factor-like domains: Implications for the Marfan syndrome and other genetic disorders [J].
Downing, AK ;
Knott, V ;
Werner, JM ;
Cardy, CM ;
Campbell, ID ;
Handford, PA .
CELL, 1996, 85 (04) :597-605
[8]   Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations:: An international study [J].
Faivre, L. ;
Collod-Beroud, G. ;
Loeys, B. L. ;
Child, A. ;
Binquet, C. ;
Gautier, E. ;
Callewaert, B. ;
Arbustini, E. ;
Mayer, K. ;
Arslan-Kirchner, M. ;
Kiotsekoglou, A. ;
Comeglio, P. ;
Marziliano, N. ;
Dietz, H. C. ;
Halliday, D. ;
Beroud, C. ;
Bonithon-Kopp, C. ;
Claustres, M. ;
Muti, C. ;
Plauchu, H. ;
Robinson, P. N. ;
Ades, L. C. ;
Biggin, A. ;
Benetts, B. ;
Brett, M. ;
Holman, K. J. ;
De Backer, J. ;
Coucke, P. ;
Francke, U. ;
De Paepe, A. ;
Jondeau, G. ;
Boileau, C. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 81 (03) :454-466
[9]   Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome [J].
Franken, Romy ;
Teixido-Tura, Gisela ;
Brion, Maria ;
Forteza, Alberto ;
Rodriguez-Palomares, Jose ;
Gutierrez, Laura ;
Garcia Dorado, David ;
Pals, Gerard ;
Mulder, Barbara J. M. ;
Evangelista, Artur .
HEART, 2017, 103 (22) :1795-1799
[10]   Allelic variation in normal human FBN1 expression in a family with Marfan syndrome:: a potential modifier of phenotype? [J].
Hutchinson, S ;
Furger, A ;
Halliday, D ;
Judge, DP ;
Jefferson, A ;
Dietz, HC ;
Firth, H ;
Handford, PA .
HUMAN MOLECULAR GENETICS, 2003, 12 (18) :2269-2276